rs754311223

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_001145715.3(KPNA7):​c.631C>G​(p.Leu211Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000827 in 1,500,082 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L211R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000079 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000083 ( 0 hom. )

Consequence

KPNA7
NM_001145715.3 missense

Scores

18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.0270

Publications

1 publications found
Variant links:
Genes affected
KPNA7 (HGNC:21839): (karyopherin subunit alpha 7) The transport of molecules between the nucleus and the cytoplasm in eukaryotic cells is mediated by the nuclear pore complex (NPC), which consists of 60-100 proteins. Small molecules (up to 70 kD) can pass through the nuclear pore by nonselective diffusion while larger molecules are transported by an active process. The protein encoded by this gene belongs to the importin alpha family, and is involved in nuclear protein import, but exhibits different nuclear localization signal binding specificity compared to other members of the family. A pseudogene of this gene has been defined on chromosome 5. [provided by RefSeq, Jul 2016]
KPNA7 Gene-Disease associations (from GenCC):
  • oocyte/zygote/embryo maturation arrest 17
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • partial corpus callosum agenesis-cerebellar vermis hypoplasia with posterior fossa cysts syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010759205).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KPNA7NM_001145715.3 linkc.631C>G p.Leu211Val missense_variant Exon 6 of 11 ENST00000327442.7 NP_001139187.1 A9QM74

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KPNA7ENST00000327442.7 linkc.631C>G p.Leu211Val missense_variant Exon 6 of 11 1 NM_001145715.3 ENSP00000330878.6 A9QM74
KPNA7ENST00000681060.1 linkc.631C>G p.Leu211Val missense_variant Exon 6 of 11 ENSP00000506489.1 A9QM74

Frequencies

GnomAD3 genomes
AF:
0.0000790
AC:
12
AN:
151960
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00249
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000250
AC:
30
AN:
120132
AF XY:
0.000328
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000317
GnomAD4 exome
AF:
0.0000831
AC:
112
AN:
1348006
Hom.:
0
Cov.:
29
AF XY:
0.000121
AC XY:
80
AN XY:
663844
show subpopulations
African (AFR)
AF:
0.0000351
AC:
1
AN:
28494
American (AMR)
AF:
0.00
AC:
0
AN:
25156
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23358
East Asian (EAS)
AF:
0.00
AC:
0
AN:
34542
South Asian (SAS)
AF:
0.00152
AC:
104
AN:
68636
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
47694
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5424
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1059212
Other (OTH)
AF:
0.000126
AC:
7
AN:
55490
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
6
12
18
24
30
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000789
AC:
12
AN:
152076
Hom.:
0
Cov.:
32
AF XY:
0.0000807
AC XY:
6
AN XY:
74334
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41528
American (AMR)
AF:
0.00
AC:
0
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00249
AC:
12
AN:
4810
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10532
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67978
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378
ExAC
AF:
0.000413
AC:
10

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Uncertain:1
Nov 14, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces leucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 211 of the KPNA7 protein (p.Leu211Val). This variant is present in population databases (rs754311223, gnomAD 0.2%). This variant has not been reported in the literature in individuals affected with KPNA7-related conditions. ClinVar contains an entry for this variant (Variation ID: 238563). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The valine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.067
BayesDel_addAF
Benign
-0.62
T
BayesDel_noAF
Benign
-0.69
CADD
Benign
0.024
DANN
Benign
0.74
DEOGEN2
Benign
0.0017
T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.076
N
M_CAP
Benign
0.019
T
MetaRNN
Benign
0.011
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.075
N
PhyloP100
-0.027
PrimateAI
Benign
0.30
T
PROVEAN
Benign
0.060
N
REVEL
Benign
0.030
Sift
Benign
0.23
T
Sift4G
Benign
0.50
T
Polyphen
0.0010
B
Vest4
0.039
MutPred
0.43
Gain of glycosylation at T210 (P = 0.0999);
MVP
0.055
ClinPred
0.056
T
GERP RS
-0.14
Varity_R
0.043
gMVP
0.087
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs754311223; hg19: chr7-98790647; API